Pyrazolo- [4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Details for Australian Patent Application No. 2005236059 (hide)

Owner Schering Corporation

Inventors Boyle, Craig D.; Neustadt, Bernard R.; Stamford, Andrew; Harris, Joel M.; Shah, Unmesh G.; Chackalamannil, Samuel; Hao, Jinsong; Liu, Hong

Agent Griffith Hack

Pub. Number AU-B-2005236059

PCT Pub. Number WO2005/103055

Priority 60/563,913 21.04.04 US; 60/609,966 15.09.04 US

Filing date 19 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 15 January 2009

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/103055 Priority application(s): WO2005/103055

15 January 2009 Application Accepted

  Published as AU-B-2005236059

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236061-Composition suitable for single-sided, low-noise, stretch cling film and films made therefrom

2005236055-Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators